Trial Profile
Effect of Reslizumab in Chronic Sinusitis with Nasal Polyposis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Mar 2018
Price :
$35
*
At a glance
- Drugs Reslizumab (Primary)
- Indications Rhinosinusitis
- Focus Therapeutic Use
- 22 Mar 2018 New trial record
- 05 Mar 2018 Results assessing efficacy of Reslizumab, presented at the 2018 Annual Meeting of the American Academy of Allergy, Asthma and Immunology